Clinical Trial Update: A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update of the recombinant MVA-BN-WEV vaccine in healthy adults for encephalitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis

Drugs mentioned

• MVA-BN-WEV vaccine

Snippet

Sponsor: Bavarian Nordic | Conditions: Encephalitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING